Related references
Note: Only part of the references are listed.Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study
Roderick C. N. van den Bergh et al.
BJU INTERNATIONAL (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
Monique J. Roobol et al.
EUROPEAN UROLOGY (2009)
Outcomes of Men with Screen-Detected Prostate Cancer Eligible for Active Surveillance Who Were Managed Expectantly
Roderick C. N. van den Bergh et al.
EUROPEAN UROLOGY (2009)
Prostate-specific antigen-based screening for prostate cancer: Evidence, controversies and future perspectives
Kazuto Ito
INTERNATIONAL JOURNAL OF UROLOGY (2009)
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Tyrol Prostate Cancer Demonstration Project: Early detection, treatment, outcome, incidence and mortality
Georg Bartsch et al.
BJU INTERNATIONAL (2008)
Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan
Kazuto Ito et al.
INTERNATIONAL JOURNAL OF UROLOGY (2008)
Prostate specific antigen (PSA)-based screening
Hiroyoshi Suzuki
INTERNATIONAL JOURNAL OF UROLOGY (2008)
Complication rates of ultrasound-guided prostate biopsy: A nation-wide survey in Japan
Yoshiyuki Kakehi et al.
INTERNATIONAL JOURNAL OF UROLOGY (2008)
Prospective evaluation of selection criteria for active surveillance in Japanese patients with stage T1cN0M0 prostate cancer
Yoshiyuki Kakehi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America
J. L. Colli et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2008)
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer - Results from a prospective, population-based randomized controlled trial
Gunnar Aus et al.
EUROPEAN UROLOGY (2007)
Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance
Stijn Roemeling et al.
EUROPEAN UROLOGY (2006)
Active surveillance with selective delayed intervention for favorable risk prostate cancer
L Klotz
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2006)
Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy
AV D'Amico et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Cumulative probability of PSA increase above 4.0 NG/ML in population-based screening for prostate cancer
K Ito et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
The risk of rapid prostate specific antigen increase in men with baseline prostate specific antigen 2.0 ng/ml or less
K Ito et al.
JOURNAL OF UROLOGY (2004)
Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
AV D'Amico et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Possibility of re-screening intervals of morethan one year in men with PSA levels of 4.0 ng/ml or less
K Ito et al.
PROSTATE (2003)
Screening men for prostate and colorectal cancer in the United States - Does practice reflect the evidence?
BE Sirovich et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer
K Ito et al.
UROLOGY (2000)
Share Paper
